Agud Martin, de Medrano Ines, Mendez-Echevarria Ana, Sainz Talia, Román Federico, Ruiz Carrascoso Guillermo, Escosa-Garcia Luis, Molina Amores Clara, Climent Francisco José, Rodríguez Aroa, Garcia-Fernandez de Villalta Marta, Calvo Cristina
Children's Medically Complex Diseases Unit, La Paz University Hospital, Paseo de la Castellana, 261, 28046, Madrid, Spain.
Paediatric Department, Universidad Autónoma de Madrid, Madrid, Spain.
Sci Rep. 2022 May 4;12(1):7223. doi: 10.1038/s41598-022-11295-5.
To assess drug-resistant bacterial colonisation rates and associated risk factors in children with complex chronic conditions admitted to a national reference unit in Spain. Cross-sectional study that included all children admitted to our unit from September 2018 to July 2019. Rectal swabs were obtained to determine multidrug-resistant Gram-negative bacilli (MR-GNB) colonisation, and nasal swab to determine S. aureus and methicillin-resistant S. aureus (MRSA) colonisation. Medical records were reviewed. 100 children were included, with a median of four complex chronic conditions. Sixteen percent had S. aureus colonisation, including two MRSA. S. aureus colonisation was associated with technology-dependent children, while being on antibiotic prophylaxis or having undergone antibiotic therapy in the previous month were protective factors. The prevalence of MR-GNB colonisation was 27%, which was associated with immunosuppressive therapy (aOR 31; 2.02-47]; p = 0.01), antibiotic prophylaxis (aOR 4.56; 1.4-14.86; p = 0.012), previously treated skin-infections (aOR 2.9; 1.07-8.14; p = 0.03), surgery in the previous year (aOR 1.4; 1.06-1.8; p = 0.014), and hospital admission in the previous year (aOR 1.79; [1.26-2.56]; p = 0.001). The rate of S. aureus nasal colonisation in this series was not high despite the presence of chronic conditions, and few cases corresponded to MRSA. Antibiotic prophylaxis, immunosuppressive therapies, history of infections, previous surgeries, and length of admission in the previous year were risk factors for MR-GNB colonisation.
评估入住西班牙一家国家参考机构的患有复杂慢性病儿童的耐药菌定植率及相关风险因素。横断面研究纳入了2018年9月至2019年7月入住本机构的所有儿童。采集直肠拭子以确定多重耐药革兰氏阴性杆菌(MR - GNB)定植情况,采集鼻拭子以确定金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌(MRSA)定植情况。查阅医疗记录。共纳入100名儿童,平均患有四种复杂慢性病。16%的儿童有金黄色葡萄球菌定植,其中包括两例MRSA。金黄色葡萄球菌定植与依赖技术的儿童相关,而接受抗生素预防或在前一个月接受过抗生素治疗则为保护因素。MR - GNB定植率为27%,与免疫抑制治疗(调整后比值比[aOR] 31;2.02 - 47];p = 0.01)、抗生素预防(aOR 4.56;1.4 - 14.86;p = 0.012)、既往治疗过的皮肤感染(aOR 2.9;1.07 - 8.14;p = 0.03)、前一年的手术(aOR 1.4;1.06 - 1.8;p = 0.014)以及前一年的住院(aOR 1.79;[1.26 - 2.56];p = 0.001)相关。尽管存在慢性病,但本系列中金黄色葡萄球菌鼻定植率不高,且很少有病例为MRSA。抗生素预防、免疫抑制治疗、感染史、既往手术以及前一年的住院时长是MR - GNB定植的风险因素。